HomeAI · summaries
Storia in 3 fonti
Future of AstraZeneca’s gene silencer in heart disease uncertain after trial failure
AstraZeneca and Ionis's Wainua misses in Phase 3 heart trial CARDIO-TTRansform, likely due to overlap with Pfizer's Vyndamax; AZ weighs next steps.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Future of AstraZeneca’s gene silencer in heart disease uncertain after trial failure
AstraZeneca and Ionis's Wainua misses in Phase 3 heart trial CARDIO-TTRansform, likely due to overlap with Pfizer's Vyndamax; AZ weighs next steps.
- ·
statnews.com
In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs
AstraZeneca detailed the surprise failure of a closely watched heart disease trial, a study with ripple effects for a competitive billion-dollar market.
